Delivery Order SPE2DB20D3103-SPE2DB24FN1B2
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical company Amerisourcebergen Corporation, to provide DOVATO 50-300 MG TABLET 30S. The $6,024.49 contract has a completion date of March 7, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order and has also received a separate indefinite delivery contract (IDC) from DLA valued up to $999,999,999.00 through December...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of $5,225.64 worth of DOVATO 50-300 MG TABLET 30S pharmaceutical products. This delivery order has a completion date of March 5, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor on this award, which is not set aside. Amerisourcebergen Drug Corp also holds an indefinite...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide DOVATO 50-300 MG tablets. The contract has a potential value of $6,626.28 and a completion date of January 31, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value up to $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide DOVATO 50-300 MG TABLET 30S, a specialty pharmaceutical product, valued at $4,832.49. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $27,934.50 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DOVATO 50-300 MG TABLET 30S, a pharmaceutical product. This delivery order contract has a completion date of February 29, 2024 and was awarded on February 28, 2024. Amerisourcebergen Drug Corp is the prime contractor on this contract, which is not designated as a set-aside. The company also...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for DOVATO 50-300 mg tablets (30-count units) with a ceiling value of $20,642.52. This competitively awarded, non-set-aside contract is priced on a firm fixed-price basis with a completion date of September 30, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DOVATO 50-300 MG TABLET 30S, a pharmaceutical product, with a potential value of $5,186.67. The award has a completion date of March 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
- This is a $16,196.43 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication DOVATO 50-300 MG TABLET 30S. The order has a completion date of July 16, 2025 and is not designated as a set-aside contract, indicating open competition. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of DOVATO 50-300 mg tablets (30-count units) valued at $30,842.10 under a firm fixed-price contract. The award was made on June 4, 2025, with an ultimate completion date of June 5, 2025, and represents a competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The $15,717.87 firm fixed-price delivery order is for the supply of DOVATO 50-300 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of September 17, 2024. Amerisourcebergen, one of the largest pharmaceutical distributors in the U.S., has been awarded this delivery order as part of its...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FN1B2Delivery Order
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply DOVATO 50-300 MG TABLET 30S, a specialty pharmaceutical product, for a total ceiling value of $90,528.59. The award, which has a period of performance through March 20, 2024, was made on March 19, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $90.5k | 3/19/24 |